Bifidobacterium adolescentis (DSM 20083) and Lactobacillus casei (Lafti L26-DSL): Probiotics Able to Block the In Vitro Adherence of Rotavirus in MA104 Cells

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1867-1314
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Bifidobacterium adolescentis (DSM 20083) and Lactobacillus casei (Lafti L26-DSL): Probiotics Able to Block the In Vitro Adherence of Rotavirus in MA104 Cells ; day:21 ; month:4 ; year:2017 ; pages:1-8
Probiotics and Antimicrobial Proteins ; (21.4.2017), 1-8

Urheber
Fernandez-Duarte, Karem Prunella
Beteiligte Personen und Organisationen
Olaya-Galán, Nury Nathalia
Salas-Cárdenas, Sandra Patricia
Lopez-Rozo, Jazmin
Gutierrez-Fernandez, Maria Fernanda
SpringerLink (Online service)

DOI
10.1007/s12602-017-9277-7
URN
urn:nbn:de:1111-201705058355
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:36 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Fernandez-Duarte, Karem Prunella
  • Olaya-Galán, Nury Nathalia
  • Salas-Cárdenas, Sandra Patricia
  • Lopez-Rozo, Jazmin
  • Gutierrez-Fernandez, Maria Fernanda
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Bifidobacterium adolescentis is intrinsically resistant to antitubercular drugs

Bifidobacterium adolescentis is intrinsically resistant to antitubercular drugs

Bifidobacterium adolescentis is resistant to pyrazinamide, isoniazid, and streptomycin

Bifidobacterium adolescentis is resistant to pyrazinamide, isoniazid, and streptomycin

Characterization of recombinant β-fructofuranosidase from Bifidobacterium adolescentisG1

Characterization of recombinant β-fructofuranosidase from Bifidobacterium adolescentisG1

What happens to Bifidobacterium adolescentis and Bifidobacterium longum ssp. longum in an experimental environment with eukaryotic cells?

What happens to Bifidobacterium adolescentis and Bifidobacterium longum ssp. longum in an experimental environment with eukaryotic cells?

Einfluß von Bifidobacterium adolescentis auf die humorale Immunreaktion gegen Bacteroides thetaiotaomicron

Hochschulschrift

Einfluß von Bifidobacterium adolescentis auf die humorale Immunreaktion gegen Bacteroides thetaiotaomicron

Bifidobacterium adolescentis induces Decorin+ macrophages via TLR2 to suppress colorectal carcinogenesis

Bifidobacterium adolescentis induces Decorin+ macrophages via TLR2 to suppress colorectal carcinogenesis

Cell factory for γ-aminobutyric acid (GABA) production using Bifidobacterium adolescentis

Cell factory for γ-aminobutyric acid (GABA) production using Bifidobacterium adolescentis

Antiviral activity of Bifidobacterium adolescentisSPM1005-A on human papillomavirus type 16

Antiviral activity of Bifidobacterium adolescentisSPM1005-A on human papillomavirus type 16

Correction: Bifidobacterium adolescentis induces Decorin+ macrophages via TLR2 to suppress colorectal carcinogenesis

Correction: Bifidobacterium adolescentis induces Decorin+ macrophages via TLR2 to suppress colorectal carcinogenesis

Bifidobacterium adolescentis-derived hypaphorine alleviates acetaminophen hepatotoxicity by promoting hepatic Cry1 expression

Bifidobacterium adolescentis-derived hypaphorine alleviates acetaminophen hepatotoxicity by promoting hepatic Cry1 expression

Metagenomic identification, purification and characterisation of the Bifidobacterium adolescentis BgaC β-galactosidase

Metagenomic identification, purification and characterisation of the Bifidobacterium adolescentis BgaC β-galactosidase

Benedictio casei.

Abschnitt (Publikation)

Benedictio casei.

Verbundene Objekte